Clinical Trials Browser

Unknown × NIH × Melanoma × Clear all

NCT00002817 2014-01-10

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Phase 1/2 Unknown

Melanoma

NCT00492505 2014-01-10

Sorafenib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Stage III Melanoma

Phase 2 Unknown

Melanoma

NCT00538005 2014-01-10

Sorafenib, Bevacizumab, and Oxaliplatin in Treating Patients With Metastatic Malignant Melanoma

Phase 1/2 Unknown

Melanoma

NCT00002767 2014-01-06

Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma

Phase 3 Unknown

Melanoma

NCT00004025 2014-01-06

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Stage III or Stage IV Melanoma

Phase 1/2 Unknown

Melanoma

NCT00010309 2014-01-06

Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma

Phase 1/2 Unknown

Melanoma

NCT00070343 2014-01-06

Oblimersen and Dacarbazine in Treating Patients With Advanced Malignant Melanoma That Has Responded to Treatment on Clinical Trial GENTA-GM301

Phase NA Unknown

Melanoma

NCT00128583 2013-12-19

Vaccine Therapy in Treating Patients With Malignant Melanoma

Phase 2 Unknown

Melanoma

NCT00022568 2013-12-18

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Phase 1 Unknown

Melanoma

NCT00037037 2013-12-18

Vaccine Therapy With or Without Sargramostim in Treating Patients With High-Risk or Metastatic Melanoma

Phase 1 Unknown

Melanoma

NCT00039234 2013-12-18

Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver

Phase 3 Unknown

Melanoma, Neoplasm Metastasis

NCT00003747 2013-09-20

Carboplatin and Temozolomide in Treating Patients With Unresectable or Metastatic Melanoma

Phase 1 Unknown

Melanoma

NCT00016055 2013-09-20

Biological Therapy and Temozolomide in Treating Patients With Metastatic Melanoma

Phase 1 Unknown

Melanoma

NCT00002781 2013-09-17

Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma

Phase 1 Unknown

Melanoma

NCT00017355 2013-09-17

Vaccine Therapy in Treating Patients With Metastatic Melanoma

Phase 1 Unknown

Melanoma

NCT00126685 2013-09-17

Vaccine Therapy in Treating Patients With Stage IV Melanoma

Phase 1/2 Unknown

Melanoma

NCT00757614 2013-08-26

Study of Genes and Environment in Patients With Cancer in East Anglia, Trent, or West Midlands Regions of the United Kingdom

14,000 enrolled

CNSDermatologicGastrointestinalGenitourinaryLymphoidOther hematologic neoplasm

Uveal Melanoma, Astrocytoma, Urinary Bladder Neoplasms, Brain Neoplasms, Carcinoma, Renal Cell, Craniopharyngioma, Esophageal Neoplasms, Hodgkin Disease, Kidney Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, Melanoma, Meningeal Neoplasms, Neoplasms, Germ Cell and Embryonal, Pancreatic Neoplasms, Pinealoma, Lymphoma, T-Cell, Cutaneous, Lymphoma, AIDS-Related, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Nephroma, Mesoblastic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Intraocular Lymphoma

NCT01018004 2013-08-26

Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II Melanoma

Melanoma

NCT01082198 2013-08-26

Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes

Phase 1/2 Unknown

Melanoma

NCT00445783 2013-08-12

Study of Families With Melanoma

Melanoma

NCT00672321 2013-08-12

Answering Questions About Vitamin D Supplementation and Sun Exposure in Patients Who Have Undergone Surgery for Stage IB, Stage II, or Stage IIIA Melanoma

Melanoma

NCT00002455 2013-08-07

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma

Phase 3 Unknown

BreastDermatologicGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Melanoma, Colorectal Neoplasms

NCT00002763 2011-11-16

High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma

Phase 3 Unknown

Melanoma

NCT00811759 2010-10-07

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

Phase 1/2 Unknown

Melanoma

NCT00085397 2009-02-09

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 2 Unknown

Melanoma

NCT00006200 2005-06-24

Thalidomide and Dacarbazine for Metastatic Melanoma

Phase 2 Unknown

Melanoma